Skip to main content
UniHealth

Doctor search

Kathleen Tam Mcmanus, PA

Physician Assistant · Stanford

NPI 1962822254

Medicare standing
1 flag on the record
Listed below.
Plans that list them
Not verified
Not the same as out of network.
Offices
3

On the public record

  • 1 Medical Board action on record

Offices

3 locations · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Kathleen Tam Mcmanus’s office at (650) 723-4000 to ask if they take your plan before you enroll.

California Medical Board record

Licence A51445 · Current

Licensed to practise in California · since 1992 · expires 2028-06-30 · Seoul National University College of Medicine. Board flags: Probation Completed.

Matched on the licence number without its letter prefix; check the name before relying on it.

Public record actions

Actions the Medical Board of California publishes for this licence
2019-10-13Board disciplineDisciplineProbation completed. · 03 2010207838

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.31 (4.24 to 6.37) · 8,661 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.1 (12.7 to 15.7) · 2,191 casesWorseJan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths4.08 (1.95 to 6.21) · 5,296 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.317BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,348 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.45 to 1.67) · 5,374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.72 to 1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths166.09 (137.88 to 194.3) · 470 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.1 · 192 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 146 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.7 · 253 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.3 · 880 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 935 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 501 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 7,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.27) · 20,799 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.14 to 0.43) · 23,182 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.94 (0.2 to 1.68) · 5,694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.54 to 3.19) · 7,846 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.2 (3.76 to 6.64) · 5,603 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.38 (0.23 to 2.53) · 2,211 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.52 (0.21 to 0.83) · 19,915 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.6 · 416 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.869No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.857No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.368No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16.2 · 247 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.5 · 1,021 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits47.8 · 258 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-1.6 · 990 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits20.8 · 976 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 959 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.4 to 6.2) · 2,191 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 425 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 183 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.7 (10.4 to 15.4) · 4,578 casesNo differentJan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Patient survey stars by topic at Stanford Health Care
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms90%

Original Medicare doctor bills

$13,155

Medicare paid this office $13,155 for 170 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Short return visit (20+ min)60$3,271$53
Return visit (30+ min)45$3,161$67
New patient visit (30+ min)33$1,636$50
Short return visit15$418$28

Procedures Medicare counted

Procedure volume Medicare published
Spinal fusion16More than 33% of doctors who do this

Who their Medicare patients are

170 Original Medicare patients in 2024. Average age 76 · Women 64% · Also on Medicaid 14% · Health risk score 1.37. Above the middle of the specialty; the typical physician assistant clinician is at 1.31.

Conditions among them: High blood pressure 70% · Coronary heart disease 31% · Depression 30% · Diabetes 24% · Chronic kidney disease 24% · Cancer 19% · Atrial fibrillation 17% · Heart failure 15% · COPD 11% · Dementia 9% · Stroke 7%.

The office billed $97,121, Medicare allowed $18,806 and paid $13,155; for 210 services of 25 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
2024170210761.37$97,121$13,155
2023176264741.25$86,395$16,496
2022143210741.23$72,325$11,287
202187124751.16$82,184$8,136
20201324711.18$41,692$1,683
20191217741.36$12,392$1,132

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 7 services

Original Medicare services billed in 2023
Return visit (30+ min)66$5,467$71
Short return visit (20+ min)56$3,399$48
New patient visit (60+ min)11$1,397$127
New patient visit (30+ min)18$1,049$58
New patient visit (45+ min)12$1,027$86
Telephone medical discussion with physician, 11-20 minutes14$714$48
Short return visit21$676$27

2022: 5 services

Original Medicare services billed in 2022
Short return visit (20+ min)65$4,555$49
Return visit (30+ min)16$1,154$72
Long return visit (40+ min)11$1,114$101
Telephone medical discussion with physician, 5-10 minutes24$709$27
Short return visit25$633$25

2021: 3 services

Original Medicare services billed in 2021
Short return visit (20+ min)39$2,724$51
New patient visit (45+ min)13$1,260$97
Short return visit18$530$28

Drugs they prescribed that Part D paid

$8,275

Pharmacies billed $8,275 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 33% of their Part D prescriptions (120 of 364) in 2024. Above the middle of the specialty; the typical physician assistant clinician is at 1%.

358 generic and fewer than 11 brand-name prescriptions · $8,275 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Celecoxib25$1,331$53
Gabapentin65$849$13
Oxycodone73$538$7
Pregabalin15$228$15
Hydrocodone-Acetaminophen21$220$10
See all 11 drugs
Every Part D drug this clinician prescribed
Celecoxib25$1,331$53
Gabapentin65$849$13
Oxycodone73$538$7
Pregabalin15$228$15
Hydrocodone-Acetaminophen21$220$10
Cyclobenzaprine13$183$14
Meloxicam13$117$9
Methylprednisolone14$105$7
Duloxetine12$104$9
Tamsulosin13$45$3
Tramadol15$37$2

Year by year

Part D prescribing by year
202436419433% (120)None$8,275
202334215923% (78)None$9,991
202242215424% (102)None$10,695
20212449621% (50)None$4,235
20201455823% (33)None$2,939
20192077828% (58)None$7,896
2018905036% (32)None$4,168
20171936623% (44)12%$15,378
20161865940% (74)15%$42,215
20151434841% (59)14%$7,912
2014312036% (11)None$2,255

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 9 drugs

Part D drugs prescribed in 2023
Celecoxib35$2,946$84
Gabapentin80$1,076$13
Duloxetine13$605$47
Oxycodone51$388$8
Pregabalin13$294$23
Cyclobenzaprine16$173$11
Meloxicam13$154$12
Hydrocodone-Acetaminophen11$104$9
Tramadol11$34$3

2022: 11 drugs

Part D drugs prescribed in 2022
Celecoxib32$1,403$44
Tizanidine12$1,357$113
Gabapentin115$1,307$11
Oxycodone57$608$11
Pregabalin18$426$24
Duloxetine12$300$25
Hydrocodone-Acetaminophen21$190$9
Tamsulosin15$107$7
Cyclobenzaprine16$99$6
Tramadol13$45$3
Amoxicillin12$15$1

2021: 5 drugs

Part D drugs prescribed in 2021
Gabapentin99$1,505$15
Celecoxib15$582$39
Oxycodone30$333$11
Duloxetine13$289$22
Hydrocodone-Acetaminophen12$100$8

2020: 4 drugs

Part D drugs prescribed in 2020
Pregabalin19$1,107$58
Gabapentin57$518$9
Oxycodone27$454$17
Duloxetine15$355$24

2019: 4 drugs

Part D drugs prescribed in 2019
Gabapentin67$902$13
Duloxetine14$518$37
Oxycodone31$338$11
Hydrocodone-Acetaminophen12$166$14

2018: 2 drugs

Part D drugs prescribed in 2018
Gabapentin22$499$23
Oxycodone15$234$16

2017: 5 drugs

Part D drugs prescribed in 2017
Lyrica21$11,634$554
Gabapentin73$978$13
Celecoxib14$805$57
Oxycodone17$301$18
Tramadol11$58$5

2016: 7 drugs

Part D drugs prescribed in 2016
Forteo12$29,682$2,474
Lyrica13$7,724$594
Gabapentin51$1,047$21
Oxycodone29$671$23
Hydrocodone-Acetaminophen17$363$21
Bd Ultra-Fine Pen Needle11$116$11
Tramadol13$72$6

2015: 3 drugs

Part D drugs prescribed in 2015
Gabapentin43$711$17
Hydrocodone-Acetaminophen19$515$27
Oxycodone16$335$21

Money from drug and device companies

$145 in 2025

Industry payments by year
202522None$145
202212None$224

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
CerapedicsI-Factor Peptide Enhanced Bone Graft$117
1 payment
  • Meals for I-Factor Peptide Enhanced Bone Graft · 2025-12-04 · $117
Merz North AmericaXeomin$28
1 payment
  • Meals for Xeomin · 2025-11-05 · $28
See all 2 published payments
Every published payment
CerapedicsMeals · 2025-12-04I-Factor Peptide Enhanced Bone Graft$117
Merz North AmericaMeals · 2025-11-05Xeomin$28
See earlier years (2022)

2022: $224

Payments by company in 2022
AmgenProlia$224
2 payments
  • Meals for Prolia · 2022-10-12 · $113
  • Meals for Evenity · 2022-04-28 · $111

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
76.5 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1962822254
Licence
CA 51445California A51445: Current · expires 2028-06-30
Video visits
Lists video visits
Gender
Female
More record details
Sole proprietor
No
Taxonomy
Physician assistant (363A00000X); Physician assistant, surgical (363AS0400X)
Mailing address
300 Pasteur Dr, Stanford, CA, 94305
NPI first listed
2014-04-24
NPI last updated
2025-12-24
NPI record certified
2025-12-24

This is when the NPI record was last certified, not a medical board exam.